Nano-cap pain management biotech Virpax Pharmaceuticals prices IPO at $10 low end

Virpax Pharmaceuticals, a preclinical biotech developing new pain management drug technology, raised $18 million by offering 1.8 million shares at $10, the low end of the range of $10 to $12. The company offered 0.4 million more shares than anticipated. At pricing, the company coRead More